Nitric oxide (NO) and hydrogen sulfide (H 2 S) are two gasotransmitters that are produced in the vasculature and contribute to the regulation of vascular tone. NO and H 2 S are synthesized in both vascular smooth muscle and endothelial cells; NO functions primarily through the sGC/cGMP pathway, and H 2 S mainly through activation of the ATP-dependent potassium channels; both leading to relaxation of vascular smooth muscle cells. A deficit in the NO/H 2 S homeostasis is involved in the pathogenesis of various cardiovascular diseases, especially hypertension. It is now becoming increasingly clear that there are important interactions between NO and H 2 S and that have a profound impact on vascular tone and this may provide insights into the new therapeutic interventions. The aim of this review is to provide a better understanding of individual and interactive roles of NO and H 2 S in vascular biology. Overall, available data indicate that both NO and H 2 S contribute to vascular (patho) physiology and in regulating blood pressure. In addition, boosting NO and H 2 S using various dietary sources or donors could be a hopeful therapeutic strategy in the management of hypertension.
Introduction
Nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H 2 S) constitute gaseous transmitters (gasotransmitters) [1] . Traditionally, all three have been considered to be toxic gases, however, we now know that they are generated in the human body and exert physiological effects in many different tissues and are particularly active in the cardiovascular system [1] [2] [3] [4] [5] [6] .
H 2 S concentration in the aorta is about 20-200 times greater than that in other tissues, indicating its vasoregulatory functions [7] . Mice that are deficient in one of the H 2 S-generating enzymes are hypertensive [8] and in rats [9, 10] as well as in mice [8] , H 2 S administration decreases arterial blood pressure indicating a physiological role for H 2 S in regulating blood pressure [11] . In addition, H 2 S-induced vasorelaxation in mesenteric arteries of genetically modified mice is more potent compared to that observed in the wild type mice, indicating super sensitivity associated with decreased endogenous production of H 2 S [8] . It has been suggested that deficiency in H 2 S-generating enzymes is an important factor that predisposes to induction of hypertension; thus, H 2 S enhancement may be an alternative approach for treating hypertension [8] (see [12] for review).
Both NO and H 2 S contribute to vascular physiology and pathophysiology [1] . They have similar biological functions with some cross talk between the enzymes that are involved in their generation. There also appears to be some interactions between the pathways that these two gasotransmitters affect (reviewed in [13, 14] ). In this review, endothelium-dependent and -independent mechanisms underlying H 2 Sinduced vasorelaxation or vasoconstriction have been discussed, we have also delved into potential interactions between H 2 S and NO that affect vascular function. Although, most effects of H 2 S are very similar to what is seen with NO [13] , it should be stressed that the role of NO in vascular physiology and signaling is well entrenched and appreciated whereas in comparison, H 2 S is relatively a new player on the scene and much is to be learned about its function in various settings. Thus, H 2 S and its role in physiology is currently a very active area of research and development.
NO and H 2 S in the pathogenesis of hypertension
Hypertension is a multifactorial disease that leads to fatal cardiovascular events as a silent killer due to chronic arterial remodeling and dysfunction [15] . Of the world's adult population, 26 .4% that is about 1 billion people had hypertension in the year 2000 and it has been estimated that the prevalence will increase to 29% or 1.5 billion people worldwide by the year 2025 [16] . Alteration of vascular structure and function through various pathways, including oxidative stress, inflammation, and endothelial dysfunction contribute to the pathogenesis of hypertension (reviewed in [17] ). The endothelium forms an important part of the vasculature and plays a key role in regulation of vascular tone by releasing of NO [18] and H 2 S [19] . Endothelial dysfunction in hypertension is associated with a decreased availability of NO and H 2 S as reviewed previously [20, 21] .
NO and the pathogenesis of hypertension
NO, which was first identified as endothelium-derived relaxing factor (EDRF) is produced by the NO-synthase (NOS) family in endothelial cells [22] . NO has a key regulatory role in maintaining proper blood pressure and its deficiency contributes to the pathogenesis of hypertension (see reviews [23] [24] [25] [26] ). In patients with essential hypertension, impairment of NO-mediated vasodilatation has been reported [27] . Recently, results of a population-based study of a cohort population of European ancestry indicates that a genetic predisposition to enhanced NO signaling (higher expression of the endothelial NOS (eNOS) and soluble guanylyl cyclase (sGC) genes) is associated with reduced levels of blood pressure, as well as lower risks of both coronary heart and peripheral arterial diseases [28] . In addition, inactivation of NO signaling is associated with higher systolic and diastolic blood pressures and a higher risk of coronary heart disease [28] .
In animal models, deletion of eNOS gene or chronic inhibition of NO synthesis leads to the development of hypertension [23] . In addition, deficiency in the release of NO by the endothelium in hypertension has been reported in clinical studies [26] . Quenching of NO or its increased degradation by superoxide anions to form peroxynitrite may lead to NO deficiency, endothelial dysfunction, and hypertension (reviewed in [27, 29] ). It has been shown that reduced NO bioavailability due to hemolysis causes pulmonary arterial hypertension and sildenafil, which potentiates NO-dependent signaling, rescues hemolysis-associated pulmonary arterial hypertension in mice [30] .
NO donors, synthetic or natural from various plants/vegetables/ fruits by increasing NO bioavailability and compensating for the NOdisrupted pathways have a therapeutic role in hypertension (as reviewed in [31] ). For example, beetroot due to its high inorganic nitrate content is considered as an adjuvant for the treatment of hypertension [32, 33] . In different animal models of hypertension, treatment with nitrate and/or nitrite, which boost NO levels, is effective in reducing elevated blood pressure [34] [35] [36] [37] . In addition, acute and short-term hypotensive effects of inorganic nitrates have been reported in several clinical studies [38] [39] [40] [41] as well as in meta-analyses [42, 43] . Results from a population-based study strongly suggested that higher dietary nitrite intake correlated with reduced risk of hypertension [44] . Also, higher intake of dietary nitrate has shown to be effective against development of hypertension [45] . Thus, the antihypertensive effects of NO-donors have implications for nutritionally based preventive and therapeutic strategies against cardiovascular disease [46] .
H 2 S and the pathogenesis of hypertension
H 2 S has been shown to be involved in blood pressure regulation [19] and its deficiency contributes to the pathogenesis of hypertension [8, 47] . Decreased cystathionine γ-lyase (CSE) activity, a specific enzyme for H 2 S production in the vasculature, decreases H 2 S production and its circulating level and leads to hypertension [47] . Deletion of CSE has a hypertensive effect [8] . Circulating levels of H 2 S can be a predictor for the development of hypertension [48] with lower plasma concentrations being associated with higher blood pressure [49] .
Administration of H 2 S donors such as sodium sulfide (Na 2 S) and sodium hydrosulfide (NaSH) reduces blood pressure in different animal models of hypertension [50] [51] [52] [53] [54] [55] . In addition, increased garlic consumption, a putative H 2 S donor, is associated with lower incidence of hypertension in some populations as reviewed in [56] . Indeed, garlic due to its high content of organosulfur compounds decreases blood pressure, which in part is due to H 2 S production [57, 58] . Development of NO-and H 2 S-releasing agents either alone or in combination, is currently an active area of research for various clinical applications including cardiovascular disease [59] [60] [61] . To sum up, reduced bioavailability of both NO and H 2 S are involved in pathogenesis of hypertension.
3. H 2 S and NO synthesis in vasculature 3.1. H 2 S synthesis in vascular smooth muscle and endothelial cells H 2 S is generated by enzymatic and non-enzymatic pathways. Nonenzymatically, H 2 S is produced by reducing elemental sulfur or organic polysulfides via glucose-supported and thiol-dependent as well as glutathione-dependent cellular reactions [57, 62, 63] . Although non-enzymatic production of H 2 S has been described in erythrocytes and has also been suggested to occur in the vasculature [57] , it is not a major source.
Most, if not all, of the biosynthesis of H 2 S has been attributed to three enzymes [12, 64, 65] , cystathionine β-synthase (CBS, EC 4.2.1.22), CSE (CGL or CTH, EC 4.4.1.1), and the tandem enzymes cysteine aminotransferase (CAT, EC 2.6.1.3) and 3-mercaptopyruvate sulfurtransferase (3-MST, EC 2.8.1.2), (Fig. 1) . Among these enzymes, CBS and CSE [2, 64] are cytosolic, 3MST and CAT are found in both cytosol and mitochondria [66, 67] . All H 2 S-producing enzymes are expressed in the vasculature [64] , however, CBS may play a negligible role in H 2 S production within cardiovascular tissues [68] . CSE, which is regulated by calcium/calmodulin [11] , along with 3-MST are mainly responsible for H 2 S biosynthesis in the cardiovascular system [3, [68] [69] [70] [71] [72] . These two enzymes are localized in both vascular smooth muscle (VSM) and endothelial cells [11, 64] . Because the concentration of cysteine in the mitochondria is much higher than that in the cytoplasm, it is conceivable that most of the H 2 S produced by 3-MST occurs within the mitochondria [63] .
Although reports are conflicting, it seems that CSE is the major H 2 Sproducing enzyme in the VSM cells [9, 11] . L-cysteine, a substrate of CSE, when added to cultured rat aorta smooth muscle cells increased H 2 S production rate thus suggesting it to be the major source for H 2 S production in VSM cells [73] . Similar to NO production [74, 75] , elevated H 2 S levels in a negative feedback manner, can inhibit H 2 S production by VSM cells [73] ; in the liver, increased H 2 S concentration by inhibiting CSE activity, decreases H 2 S production [76] . CAT mRNA is expressed in both VSM and endothelial cells [77] , however, immunohistochemistry of rat thoracic aorta showed that CAT was localized only to endothelial cells [78] . In contrast to earlier reports that endothelial cells are not a source of H 2 S [9] , expression of CSE has now been reported in the endothelial cells of mice, bovine, and humans [8, 11, 12] . It seems that at least in rats, 3-MST along with CAT are the major enzymes for producing H 2 S in endothelium [11] . In endothelial cells, H 2 S production is highly dependent on α-ketoglutarate and 3-MST, which along with CAT contribute more than CSE in H 2 S production [11, 78] . Both mitochondrial and cytosolic forms of CAT are found within the endothelial cells [78] .
H 2 S generation by periadventitial adipose tissue
H 2 S is also generated by periadventitial adipose tissue (PAT), which consist the major part of adventitia and contributes in vascular relaxation [79] . In rat, although both CBS and CSE are expressed in the PAT, H 2 S appears to be mainly generated by CSE-catalyzed L-Cysteine [79] . This is because CSE inhibitors (propargylglycine or β-cyano-Lalanine) reduce H 2 S production by more than 70% [79] . CSE-H 2 S pathway in the PAT is upregulated by phenylephrine, serotonin, or angiotensin II [79] . Moreover, in hypertensive rats where the hypertension was induced by constriction of the abdominal aorta, H 2 S synthesis and CSE expression were increased in isolated periaortic adipose tissue. Thus, the CSE-H 2 S pathway in the PAT may act as a back-up vasodilatory system in hypertension to compensate for the elevated blood pressure in response to both the acute effects of vasoconstrictors and chronic hypertension. [80] . In addition, the role of PAT-derived H 2 S may be species-specific and vary between different vascular beds, as CSE expression is much lower in mice PAT than in rat [81, 82] .
Rate of H 2 S production in vasculature
Using a polarographic H 2 S sensor, rate of H 2 S production in rat liver, brain, aorta, and heart has been reported to be 12.3 ± 4.6, 10.6 ± 3.2, 5.8 ± 1.7, and 1.1 ± 0.3 pmol/s/mg protein, respectively [73] . Tissue generation of H 2 S and in particular the liver contributes to circulating levels of H 2 S [83] . CSE expression in vascular tissues is different and can be ranked as pulmonary artery > aorta > tail artery > mesenteric artery [9] . H 2 S production rates are 3.6 ± 1.3, 8.7 ± 2.7, and 3.4 ± 0.7 nmol/min/g tissue for the aorta, tail artery, and mesenteric artery, respectively [84] ; in addition, H 2 S concentration in smooth muscle cells can be ∼100 μM in certain blood vessels [84] .
NO synthesis in vasculature
As shown in Fig. 1 , NO is produced in all tissues [85] [86] [87] [88] by NOS- Fig. 1 . Hydrogen sulfide and nitric oxide biosynthetic pathways in vessels. Hydrogen sulfide (H 2 S) and nitric oxide (NO) are generated by enzymatic and non-enzymatic pathways. Nonenzymatic production of H 2 dependent (L-arginine-NO pathway) and independent (nitrate-nitrite-NO pathway) pathways [89, 90] . NO is mostly produced from L-arginine by the enzymes known as NOS (reviewed in [91] ). There are three isoforms of NOS including constitutive neuronal (nNOS/NOS1), inducible (iNOS/NOS2), and constitutive eNOS (NOS3) [91] . The existence of a mitochondrial NOS has also been reported [92] , although this is a debatable issue as there is always a small percentage (1-4%) of contamination in mitochondrial preparations which may contain NOS from extra-mitochondrial sources [87, 93] . In any case, even if such a NOS does exist, its physiological relevance is not immediately apparent. The largest source of eNOS and nNOS are the endothelium and skeletal muscle, respectively [94] . NO production from nitrate-nitrite-NO pathway may contribute to the therapeutic effects of nitrate/nitrite in various disorders including hypertension [95, 96] (reviewed in [97, 89] ). All NOS isoforms are expressed in VSM [98] and endothelial [99] cells and eNOS is the major isoform regulating vascular function [50] . Expression of NOS isoforms in elastic type vessels like aorta is lower than the muscular type arteries and arterioles; in addition, it seems that nNOS is the major and eNOS is the minor NOS isoform in VSM cells [98] . While it has been reported that both VSM and endothelial cells generate NO, the production of NO by the VSM cells is however not sufficient to relax endothelium-deprived vascular preparations of bovine pulmonary arteries [100] . However, other studies have suggested that NO production by the VSM cells is sufficient to modulate vascular contractility in bovine carotid and human renal arteries [101] and rat aorta [102] . This apparent discrepancy may stem from the different types of blood vessels investigated as in VSM cells, the expression pattern of NOS isoforms varies in different types of blood vessel [98] . In the blood vessel walls, NO is mainly produced from the L-arginineeNOS pathway [103] .
In addition to NO production by the endothelial and VSM cells, all blood cells also produce NO (monocytes > neutrophils > lymphocytes > red blood cells (RBCs) > platelets) [104] (reviewed in [105] ), which may contribute to regulation of vascular homeostasis [104] . Platelet-derived NO, inhibits platelet activity and can modulate thrombosis [105] . In hypertensive patients, platelet-derived NO decreases which suggests a link between altered platelets function and hypertension [106] . Under physiological states, eNOS-derived NO from blood cells decreases blood pressure [107] and RBC eNOS expression and activity are compromised in patients with coronary artery disease [104] . RBCs play an important role in regulation of vascular tone by regulating local H 2 S levels. H 2 S, whether generated in RBCs by 3-MST or diffused into RBCs from blood, binds to hemoglobin and is oxidized to thiosulfate and hydropolysulfides [108] ; myoglobin shows a similar capacity for H 2 S oxidation [109] .
Rate of NO production
In mice, total production of NO is about 0.2 mmol/kg/day of which approximately 70% is derived from eNOS [110] . The largest source of eNOS is the endothelium [94] . The rate of NO formation in Wistar rats and humans has been reported to be 0.33-0.85 µmol/kg/h and about 0.9 µmol/kg/h, respectively [111] [112] [113] [114] with the vascular endothelium being the main site of NO synthesis [115] .
To summarize, CSE is the major H 2 S-producing enzyme in VSM cells and eNOS is the main source for NO generation in vasculature. In addition, blood cells produce both NO and H 2 S that may contribute to the regulation of vascular tone.
Major types of ion channels in VSM and endothelial cells
Ion channels constitute one major group of target proteins regulated by H 2 S [70] . VSM cells express many ion channels ( [130] are also expressed in VSM cells, IP 3 R 1 is however the predominant isoform [125] . RyR s have been found in macrovascular but not microvascular endothelial cells [131] [132] [133] [134] . All three isoforms of IP 3 R are expressed in endothelial cells and IP 3 R 2 and IP 3 R 3 are largely restricted to the endothelium [135] . TRP channels are non-selectively permeable to cations [136] . Activation of most TRP channels results in a rise in [Ca 2+ ] i , and leads to various vascular responses, including changes in vascular tone [137] . At least 19 TRP channels have been found in vascular endothelial cells [137] . In VSM cells, TRPC3, -C6, and -M4 contribute to membrane depolarization [137, 138] and TRPV4 contributes to membrane hyperpolarization by stimulating RyR and BK Ca channels [137] [138] [139] . The effects of H 2 S on Ca
2+
-release channels in ER/SR membrane have been described in Section 7.1.4. ] i and RLC 20 dephosphorylation by myosin light chain phosphatase (MLCP) cause relaxation [142, 143, 146] . DAG activates protein kinase C (PKC), which phosphorylates downstream targets that are involved in contraction including MLCK and Rho kinase (ROK), a Ser/Thr kinase [143, 145] . The effects of H 2 S and NO on this pathway have been described in Sections 13.2 and 9.1.1, respectively.
Ca 2+ sensitization
It has been shown that agonist-induced force is greater than depolarization-induced force at similar or lower [Ca 2+ ] i , a phenomenon that is due to agonist-induced Ca 2+ -sensitization of the contractile/regulatory apparatus [145, 147] . PKC and ROK (Rho's primary effector) signaling pathways contribute to Ca 2+ sensitization [143] . Activation of Rho, which is a small monomeric G-protein, promotes ROK-dependent phosphorylation of Thr695 and Thr850 on myosin-binding subunit (MBS), also named myosin phosphatase target subunit (MYPT1) in MLCP and increases contraction [143, 145] . Inhibition of MLCP by Rho causes Ca 2+ sensitization and over activity of Rho-ROK pathway is implicated in hypertension [142] . In addition to Gq/11, vasoconstrictor receptors are coupled to G12/13, which activates Rho guanine nucleotide exchange factors (GEFs) and then ROK [142, 143] . Both ROK and PKC phosphorylate and activate PKC-potentiated inhibitor protein (CPI-17), which inhibits MLCP [143] . Ratio of MLCK activity-to MLCP activity is a major determinant of Ca 2+ sensitivity in VSM [147, 148] ( Fig. 3 ).
H 2 S-induced vasorelaxation
H 2 S-induced vasorelaxation was first reported by Hosoki et al. (1997) in portal vein and thoracic aorta [149] . Zhao et al. (2001) showed that H 2 S induces a dose-dependent relaxation of phenylephrine-precontracted rat aorta (IC 50 , 125 ± 14 μM) with a threshold concentration of 60 μM; they also showed that H 2 S acts through opening of K ATP channels [9] . Relaxing response to H 2 S on VSM has been observed in large vessels [3] but it has more of an effect on small resistance rather than large conduit arteries [3, 64, 69, 150] . For example, H 2 S is 5-fold more potent in relaxing rat mesenteric artery (EC 50 , 25.2 ± 3.6 μM) than rat aorta (EC 50 , 125 ± 14 μM) [151] . Unlike H 2 S, NO primarily acts on larger vessels [83] . In addition, there is heterogeneity in vascular response to H 2 S [64] and vascular actions of H 2 S is different between species and strains [4] . These differences may be related to different oxygen sensitivity of blood vessels to H 2 S and also different sensitivities of contractile proteins to H 2 S and intracellular calcium levels (reviewed in [152] ). At physiological O 2 levels, H 2 S causes vasorelaxation, this effect is promoted at below physiological O 2 levels while it induces vasoconstriction at higher than physiological O 2 levels; oxygen consumption rate at small peripheral vessels due to the high content of VSM cells is high and these vessels have lower oxygen partial pressure [153] . Different distribution of the molecular targets of H 2 S like K ATP channels in tissues has also been suggested [152] . A recent review has summarized the effects of H 2 S on vascular tone in different experimental settings [154] .
Mechanisms of H 2 S-induced vasorelaxation
It seems that H 2 S acts through different pathways for relaxation of vascular beds [7, 64] (Fig. 2) . H 2 S-induced vasorelaxation involves mostly endothelium-independent (i.e. a direct effect on VSM cells) and to a lesser extent endothelium-dependent mechanisms [4, 7, 9, 155] . Endothelium-independent mechanisms by which H 2 S exerts its vasorelaxatory effects include activation of K + channels [3, 4, 7, 9, 116] , decrease in intracellular pH [7, 155, 156] , and metabolic inhibition [155, 157] . Endothelium-dependent mechanisms include release of NO and/or endothelium-derived hyperpolarizing factor (EDHF) [158] .
7.1. Endothelium-independent mechanisms 7.1.1. Effects of H 2 S on K ATP channels Activation of potassium channels and in particular K ATP channels is one of the primary mechanisms underlying H 2 S-induced vasorelaxation [3, 9, 69, 70, 151] (Fig. 2) . H 2 S stimulates (opens) K ATP channels on VSM and hyperpolarizes membrane potential [3, 68, 70, 158] , which closes VDCC, reduces intracellular Ca 2+ and results in smooth muscle relaxation [7, 68, 70] . SUR S are sites of modulation by H 2 S as K + currents generated by K ir subunits are insensitive to H 2 S [70] . In addition, H 2 S increases open probability of K ATP channels independent of ATP levels [70] . H 2 S interacts with Cys6 and Cys26 residues on extracellular Nterminal of rat vascular SUR1 (rvSUR1) subunit of K ATP channels and possibly modifies it through S-sulfhydration (Section 13 for more details) thus opening the channel [68] . It should be noted that the vasorelaxatory effects of H 2 S are not exert through K ATP channels only [155, 156] as it has been reported that glibenclamide only partially prevents H 2 S-induced vasorelaxation [3, 69, 155] or even has no effect [4, 155] . In addition, contribution of K ATP channels in H 2 S-induced vasorelaxation are different among various vascular tissues [7] and the effects are minimal in rat coronary arteries [7] , where K v contributes to this function [7] . In rats, activation of K ATP channels by H 2 S is strong in mesenteric and aorta but is weak in coronary arteries [7] .
7.1.2. Effects of H 2 S on K v channels H 2 S, as an adipocyte-derived relaxing factor (ADRF), which is released by PAT (Fig. 2) , activates K v 7.x channels in VSM and produces relaxation [7, 116] , this pathway is known as the ADRF-K v pathway [150] . K v 7 channels activate at ∼−60 mV and keep resting membrane voltage far from threshold for activation of voltage-gated Ca 2+ channels (∼−40 mV), this effect prevents vasoconstriction [3] . Four-aminopyridine (4-AP), which blocks many classes of K v channels other than K v 7, did not affect H 2 S-induced vasorelaxation while linopirdine, a rather selective K v 7 blocker, significantly reduced H 2 S-induced vasorelaxation in the rat thoracic aorta [3] . The molecular target for PATderived H 2 S in smooth muscle cells varies depending on the vessel size (reviewed in [159] and K v channels on VSM and causes hyperpolarization (7). In endothelium, H 2 S causes hyperpolarization through activation of SK Ca , IK Ca , and BK Ca channels and also K ATP channels (8); hyperpolarization transfer from endothelial to VSM cells via myoepithelial gap junctions (MEGJ) (9). In addition, H 2 S increases intracellular Ca 2+ concentration by acting on phospholipase Cβ (PLCβ) (10) , and transient receptor potential (TRP) channels (11) , which favor reverse mode of Na + -Ca 2+ exchanger (NCX) (12) , and activates cytochrome P450 epoxygenase (Cyp2C) (13) and production of epoxyeicosatrienoic acid (EET) (14) ; EET diffuse to VSM and activates Ca 2+ sparks (15) , which leads to relaxation. ER, endoplasmic reticulum; SR, sarcoplasmic reticulum; DAG, diacylglycerol; RyRs, ryanodine receptors.
frequency in endothelium-intact rat mesenteric arteries. These findings indicate that endogenous H 2 S activates Ca 2+ sparks, which activate BK Ca channels and produce hyperpolarization and therefore VSM relaxation [161] . It has however been reported that BK Ca channels, found in VSM cells, do not contribute to the H 2 S-induced vasorelaxation [158] . Effects of H 2 S on BK Ca appear to be tissue-specific as it has been reported that H 2 S activates the channel in small endothelium-intact mesenteric arteries [69] , endothelial cells of small mesenteric arteries [161] , and other tissues [163, 164] and inhibits the channel in some other tissues [161, 165] (Fig. 2) .
Changes in intracellular pH
Intracellular acidification causes vasorelaxation while alkalinization causes vasoconstriction [7, 156, 162] . Intracellular pH (pH i ) in VSM cells (7.1-7.2) is maintained by buffering systems (HCO 3 − /CO 2 and proteins) and also ionic exchangers (sodium-hydrogen exchanger (NHE), anion exchanger (AE), and Ca 2+ -ATPase) [7, 156] . H 2 S activates chloride-bicarbonate exchanger (CBE), which decreases pH i and activates K ATP channels [7] , (Fig. 2) . NaSH decreases pH i in embryonic rat aortic smooth muscle cells (A7r5 cells) in a dose-dependent manner, an effect that is significantly attenuated by inhibition of CBE [156] . In fact, NaSH increases the CBE activity by ∼ 60% in A7r5 cells, this effect may be due to PKC or PKA activation [156] . In this study, DIDS (4,4′-diisothiocyanatostilbene-2,2′-disulfonic acid disodium salt hydrate), which is a CBE inhibitor, abolished NaSH-induced relaxation in KCl precontracted aortic rings of male Sprague-Dawley young rats [156] . It should be noted that H 2 S is a weak acid (pK a1 value of 6.76 and pK a2 > 12 at 37°C [7, 13, 65] , i.e. only 18.5% of H 2 S remains undissociated at physiologic pH (7.4)) [7] and this in fact could decrease the pH i , thus limiting the findings reported [156] . Inhibition of CBE by DIDS completely prevents H 2 S-induced vasorelaxation on precontracted thoracic aorta in rats [155] . Therefore, it appears that H 2 S decreases pH i in a concentration-dependent manner [7] and this at least in part may contribute to the H 2 Sinduced vasorelaxation [156] . Supporting this notion are reports that vascular K ATP channels are pH-sensitive and intracellular acidification activates K ATP channels [155, 162, 172] and decreases Ca 2+ influx through VDCC [162] . It has however been reported that high doses of Na 2 S (300 μM and 1 mM) induces an alkaline shift in pH (7.4-7.54 and 7.75, respectively) [167] and that this could potentially activate RyR in smooth muscle cells of piglet cerebral arteriole [173, 174] . 
Metabolic inhibition
In vitro and in vivo studies have shown that H 2 S and NO inhibit cytochrome c oxidase, the terminal enzyme in the mitochondrial respiratory chain [157, 180] . NO inhibits cytochrome oxidase in vitro, however, this issue is still disputable as to whether NO is an in vivo inhibitor of the enzyme [157] . At physiological O 2 levels, sGC is ∼50-fold more sensitive to NO than to cytochrome oxidase [157] and inhibition of cytochrome oxidase by NO is unlikely to participate in vasorelaxation.
In vivo, H 2 S at 50 ppm, inhibits cytochrome c oxidase in lung mitochondrion of rats [180] . In vitro, H 2 S dose-dependently and in a noncompetitive manner inhibits cytochrome c oxidase (IC 50 = 1.2 ± 0.3 μM) in lung mitochondrion of rats [180] . In rat thoracic aortic rings, H 2 S causes ∼35% decrease in ATP levels in about 10 s [155] . Inhibition of cytochrome oxidase by H 2 S may contribute to a decrease in cellular ATP levels and activation of K ATP channels [157] . However, H 2 S could activate K ATP channels in presence of elevated levels of ATP and mediate vasorelaxation independent of a decrease in cellular ATP levels [153] . In intact cells, respiration of mitochondria is half inhibited at 30 μM of H 2 S [157] . As H 2 S is a substrate for mitochondrial respiratory chain, it increases O 2 consumption at low concentrations and inhibits O 2 consumption at high concentrations (> 20 μM) [157] . Like NO, there is no firm evidence that H 2 S is a significant inhibitor of respiration in vivo [157] .
Endothelium-dependent mechanisms
An increase in IC 50 of H 2 S-induced relaxation of phenylephrineprecontracted aorta has been reported following removal of endothelium with saponin (135.5 ± 14 to 273 ± 16 μM), indicating that H 2 S-induced vasorelaxation is facilitated by the endothelium [84] ; in addition, inhibition of NO production increases the IC 50 of H 2 S-induced relaxation [84] . The same results have been reported for mesenteric artery, where endothelium removal reduced H 2 S-induced relaxation by 6.4-fold (EC 50 of H 2 S were 25.2 ± 3.6 vs. 160.8 ± 8.6 μM in presence and absence of endothelium, respectively) [151] . (Fig. 2 ).
H 2 S as an EDHF candidate
Depending on vascular beds and species, EDHF is an amalgam of different mechanisms and compounds [182] . Putative EDHFs include prostaglandin I 2 (PGI 2 ), epoxyeicosatrienoic acid, H 2 O 2 , potassium ions, C-type natriuretic peptide and NO [83] . H 2 S also acts as an EDHF candidate [83, 158] . Classical endothelium-dependent hyperpolarization response is initiated in the endothelium following increases in intracellular Ca 2+ [183] , both of which hyperpolarize VSM cells [183] . H 2 S may diffuse from endothelial to VSM cell through MEGJ [83] (Fig. 2) . Collectively, H 2 S-induced vasorelaxation is mostly endothelium-independent and is mostly achieved through modulation of ion channels and in particular K ATP channels; other mechanisms including acidification of intracellular fluid may also play a role.
H 2 S -induced VSM cell contraction
In addition to relaxation, which seems to be the primary action of H 2 S on the vasculature [64] , H 2 S can also exert VSM contraction under some conditions [155] . H 2 S exerts biphasic effect on vascular tissue and produces vasoconstriction at lower concentrations (10-100 μM of NaSH yields ∼3-30 μM H 2 S) in rat aorta [10, 186] or 30-100 μM of H 2 S in rat and mouse aortae [4] and vasorelaxation at higher concentrations, i.e. > 60 μM [7, 158, 186] ; in physiological solutions, about one-third of NaSH exists as H 2 S [186] . It has been argued that contractile activity of H 2 S on blood vessels, which needs lower concentrations, is physiologically more important than its relaxant activity, which needs higher concentrations [187] . H 2 S-induced vasoconstriction may be due to NO quenching [7] or inactivation [158] /inhibition of eNOS [7] , and NOindependent mechanisms [94] including lowering cyclic adenosine monophosphate (cAMP) levels in VSM cells at high concentrations [94] .
Inhibition of NO by H 2 S
Contractile activity of H 2 S in phenylephrine-precontracted rat aorta disappeared after endothelium removal, NOS inhibition, or sGC inhibition [4] . Contractile effect of H 2 S is endothelium-dependent [10] and involves the NO-cGMP pathway [187] . In addition, H 2 S reduces acetylcholine-induced relaxation but not sodium nitroprusside (SNP)-induced relaxation [187] . H 2 S at 30-3000 μM inhibits eNOS activity in a concentration-dependent manner, which contributes to its vasoconstrictor activity [187] . However, H 2 S also quenches endogenous NO release from phenylephrine -precontracted endothelium of intact aortic rings [10] . H 2 S stimulates AE 2 , the predominant isoform of anion exchangers in VSM cells [188] . Of note, an influx of bicarbonate and efflux of superoxide anions has been associated with NO inactivation and vasoconstriction [3] . H 2 S-induced stimulation of AE 2 causes extracellular accumulation of superoxide anions, which may react with NO [188] . In addition, Tiron (a superoxide scavenger) increases H 2 S-induced vasorelaxation at high doses and decreases H 2 S-induced vasoconstriction at low doses [188] . The suppression effect of H 2 S on NO production may therefore be involved in the increased activity of AE 2 as DIDS reversed the NO lowering effect of H 2 S and abolished the vasoconstrictor effects of low concentrations of H 2 S [188] . In addition, when HCO 3 − was added to the HEPES buffer, H 2 S-induced vasorelaxation in KCl-precontracted rat aorta was reduced [188] .
Reduction in cAMP levels
cAMP is produced from ATP by adenylyl cyclase (AC), of which nine isoforms (ACI-IX) has been identified; isoforms III, IV, V, VI, and VIII are expressed in vascular vessels [186] . Decreased cAMP levels contributes to H 2 S-induced vasoconstriction as low concentrations of NaSH (50-100 μM) causes vasoconstriction in isoprenaline, salbutamol, and forskolin (an activator of AC)-relaxed aortic rings in rat [186] . Low concentrations of NaSH also suppress forskolin-induced cAMP accumulation in aortic smooth muscle cell line (A7r5 cells) [186] .
Variation in oxygen pressure
Oxygen tension is an important factor for controlling vascular responses to H 2 S [153] . H 2 S-induced vasorelaxation is more prominent in absence of oxygen rather than in its presence [155] . EC 50 for H 2 S-induced relaxation in phenylephrine-precontrated rat aorta at 40 μM O 2 is about 17-fold lower than that at 200 μM O 2 (14.6 µM vs. 256 μM) [153] . Under physiological O 2 conditions, H 2 S relaxes vessels but it causes contraction of aortic smooth muscle at high O 2 levels [11] . Low concentrations of H 2 S in presence of high oxygen (95%), under which H 2 S is rapidly oxidized and less available, produce vasoconstriction [153, 155] ; this vasoconstriction may be due to H 2 S oxidation products [153] . H 2 S may compete with oxygen at the level of cytochrome c, and therefore the vasorelaxation by H 2 S is less pronounced in the presence of higher oxygen concentration [155] .
To sum up, H 2 S in addition to having vasorelaxatory effects, it could also produce vasoconstriction; this effect is highly dose dependent however, its underlying mechanism(s) has not been completely elucidated; effects on NO production and oxygen availability may be involved in this dual action.
NO-induced vasorelaxation
NO is the most potent endogenous vasorelaxant [189] . Vascular NO production is mostly due to eNOS activity in endothelium; eNOS-derived NO reaches its targets on the endothelial cells or diffuse into VSM cells [13] . Actions of NO could be cGMP-dependent as well as cGMPindependent (mostly reactive nitrogen species-mediated) [190] , (Fig. 3) .
cGMP-dependent actions
GC activation, generation of cGMP and activation of PKG are the most important physiologic signaling pathway activated by NO (Fig. 3 ) [90, 97, 169, 191, 192] . Low nM concentrations of NO reversibly activate GC [157, 192, 193] , which converts guanosine triphosphate to cGMP [193] . GC has two isoforms: soluble (cytosolic) and membrane (particulate); the receptor for NO is sGC [193] , which is a heterodimer of α and β subunits [193] and contains a ferrous heme prosthetic group on histidine 105 residue of the β subunit [193] . When NO binds to the ferrous heme iron, histidine 105 is disrupted and inhibition of the catalytic activity of sGC by the heme is overcome yielding an increase in V max and a decrease in K m of the enzyme (reviewed in [193] ). cGMPdependent PKG, cGMP-gated cation channels, and cGMP-specific PDE 5 are among the targets of cGMP [194, 195] . H 2 S via sulfhydration of PDE 5 , inhibits its activity and rises cGMP level in vascular tissues [196] . PKG is a serine/threonine kinase and exists as a homodimer [195] . Two isoforms of PKG have been found in mammalian cells, viz. PKGI and PKGII [197] ; PKGI activates PDE 5 and provides a negative-feedback loop [195] . Vascular cGMP is degraded by PDE 5 [13] . Activation of PKG by cGMP is responsible for NO-induced vasorelaxation [13] , (Fig. 3) .
Vasodilatory mechanisms of NO/cGMP/PKG pathway
PKGI family is more commonly involved in NO/cGMP/PKG signaling pathway [148] , which exerts its vasodilatory effects in VSM cells via a decrease in both [Ca 2+ ] i [198] and Ca 2+ sensitivity [143] .
Decreases in [Ca

2+
] i is achieved through three different mechanisms: (1) decreased IP 3 -mediated Ca 2+ release from SR by phosphorylation of IP 3 R 1 -associated cGMP kinase substrate at Ser696 and decreased generation of IP 3 by phosphorylation of G-protein-activated PLCβ3 at Ser26 and Ser1105 [103, 148, 199, 200] ; (2) increased Ca 2+ -sequestration by phosphorylation of phospholamban at Ser16 and increased sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) activation [201] ; (3) decreased Ca 2+ entry induced by hyperpolarization, which is generated by activation of K + channels (K v 2.1, K ATP , Kir2.1 and BK Ca channels) [198, [202] [203] [204] [205] [206] , and also decreased activity of Ca 2+ channels (Ca v 1.2, TRPC1,3,6) [137, 138, [207] [208] [209] [210] [211] [212] ]. An NO-induced decrease in Ca 2+ sensitivity is achieved thorough decreasing activity of Rho/ROK pathway [143] . PKGI phosphorylates Rho at Ser188 and MBS of MLCP at Ser695, and therefore decreases inhibitory effect of ROK on the MLCP and causes vasorelaxation [148, [213] [214] [215] . PKGI also phosphorylates and translocates Rho from plasma membrane to the cytosol, where is inactive [148, 213] . In addition, PKGI increases activity of regulator of G-protein signaling 2 (RGS2), which decreases both [Ca 2+ ] i and Ca 2+ sensitivity [143] .
cGMP-independent actions
NO reduces [Ca 2+ ] i in rabbit carotid artery by increasing Ca 2+ uptake by SR; this effect is mostly cGMP-independent and occurs via SERCA activation [144, 216] . NO activates SERCA in VSM cells and decreases [Ca 2+ ] i , this causes refilling of intracellular Ca 2+ stores and inhibits store-operated Ca 2+ entry and relaxation [144] . In fact, under physiological conditions, NO can react with superoxide anion to produce peroxynitrite (ONOO − ), which in turn activates SERCA by reversible S-glutathionylation (GSS-) that forms GSS-SERCA at cys674 [216] (Fig. 3) . Low concentrations of ONOO − (10-50 μM) increases SERCA activity in aortic homogenates while higher concentrations (> 100 μM) inhibits it [216] . Using rabbit aorta, it has also been shown that NO can directly interact with BK Ca channels thus increasing channel activity [217] . In addition, NO increases the frequency of Ca 2+ sparks [218] by S-nitrosylation and activates RyRs [219] and in turn the activity of BK Ca channels in rat cerebral artery (reviewed in [218] ).
Interaction between H 2 S and NO
H 2 S and NO influence each other at the level of biosynthesis (Fig. 1 ) and biological responses as reviewed in [220] (Fig. 2) . Hosoki et al. initially reported that NaSH at a concentration that does not produce vascular relaxation (30 μM), potentiates the vasorelaxatory effects of SNP, with decreasing its EC 50 by ∼13-fold [149] . It has been suggested that physiological role of H 2 S is regulation of local concentrations of NO [10] .
Effect of H 2 S on NO production and bioavailability
Effects of H 2 S on NO production/bioavailability are complex and include effects on NOS enzymes, L-arginine transport, and NO release from its storage forms. H 2 S inhibits L-arginine transport in human umbilical vein endothelial cells [7] and increases NO release from NO storage pools (e.g. nitrite) [13] , which in part is catalyzed by xanthine oxidase [13] .
Effect of H 2 S on activity, mRNA expression, and protein expression of NOS isoforms is controversial. It has been reported that H 2 S increases activity of eNOS [13, 68, 221] , has no effect on iNOS and nNOS activities [7] , or inhibits all NOS isoforms [187] . These differences may be related at least in part to the time of NOS activity measurement after H 2 S exposure as stimulatory effects of H 2 S on eNOS activity is transient [222] . In addition, L-cysteine at low concentrations increases the activity of nNOS and iNOS but not that of eNOS, and at high concentrations, it inhibits the activity of all NOS isoforms [187] . The biological interactions of NO and H 2 S are complicated, and these discrepancies may be due to various experimental conditions, vascular bed, species, cell type, and H 2 S dose [63, 149, 223] ; so further elucidations are needed to improve our understanding as to how H 2 S and NO can reciprocally regulate their synthetic enzymatic pathways. eNOS is mostly expressed in the endothelium [224] but CSE is present in both the endothelium and VSM cells [9] ; so when endothelium is impaired and NO is reduced, H 2 S is still produced by the VSM cells and can represent a backup system within the vasculature in pathological conditions [224] .
The stimulatory effects of H 2 S on eNOS activity is partly due to an increase in [Ca 2+ ] i within the endothelial cells [1, 13, 68, 83, 189, 225, 226] ; increased intracellular calcium is a rapid and potent activator of eNOS [13] , causing phosphorylation of S1177 on human eNOS [64, 189, 227] , and inhibiting the S-nitrosylation of eNOS [228] . In addition, H 2 S prevents oxidized low-density lipoprotein mediated proteasome dependent eNOS degradation [227] and stabilizes the dimeric active form of eNOS [64] through sulfhydration of Cys443 [13, 228] .
Elevation of endothelial [Ca 2+ ] i by ligands such as acetylcholine induces relaxation of adjacent VSM cells through endothelium-derived relaxing factors including NO, PGI 2 , and EDHF [13, 182] . In primary cultures of human endothelial cells derived from saphenous veins, NaSH increased [Ca 2+ ] i at concentrations ≥50 μM independently of extracellular Ca 2+ , indicating the importance of intracellular Ca 2+ pools as well as IP 3 R and RyR [225] . In bovine aortic endothelial cells, NaSH increased NO production in a dose-dependent manner through the Ca 2+ /CaM pathway [189] . This effect was independent of extracellular Ca 2+ and was a result of Ca 2+ release from ER through IP 3 R and RyR [189] . In human umbilical vein-derived EA.hy926 cells, NaSH increased intracellular Ca 2+ with a peak at 30 μM; this effect was in- ] i is achieved by increasing IP 3 -dependent intracellular Ca 2+ mobilization, activating K ATP channels, and favoring the reverse mode of NCX [1, 13, 68] . Molecular mechanism underlying endothelial Ca 2+ mobilization are however different depending on species and vessel type [1, 226] . Administration of NaSH (56 µmol/kg/day for 20 week) to hypertensive rats improves the endothelium-dependent relaxation; this effect was shown to be due to inhibition of the renin-angiotensin system and activation of eNOS by phosphorylation [230] . It has also been reported that NaSH inhibits eNOS in a concentration-dependent manner with an IC 50 of 170 μM [4] . Inhibitory effects of H 2 S on eNOS are due to inhibition of tetrahydrobiopterin (BH 4 ) functions [187] and reducing the phospho-eNOS (serine 1177) [231] . BH 4 is needed to stabilize the active dimeric form of all NOS isoforms [99] . Proper dimerization (coupling) is important for NOS activity [232] and NOS monomers cannot catalyze NO production [94] . Mammalian NOSs catalyzes oxidation of L-arginine to NO and L-citrulline [233] using molecular oxygen and reduced nicotinamide-adenine-dinucleotide phosphate as co-substrates, and flavin mononucleotide, flavin adenine dinucleotide, and BH 4 as cofactors [193, 234] , from which BH 4 is essential and rate-limiting [87] . In cultured mouse aortic endothelial cells, H 2 S by reducing the phospho-eNOS (serine 1177) levels inhibits eNOS activity [231] . Consistent with these reports, in isolated rat aorta and cultured human umbilical vein endothelial cells, administration of H 2 S decreased the activity of the L-arginine/NOS/NO pathway [235] .
Effect of NO on H 2 S production
Effects of NO on H 2 S production are also not straightforward. In vascular tissues, NO increases activity and expression of CSE enhancing H 2 S production [9, 11, 70, 181, 187, 223] , (Fig. 1) . Zhao et al. showed that incubating homogenized rat vascular tissues with SNP increases H 2 S production; in this study, another NO donor, s-nitroso-N-acetylpenicillamine (SNAP), increased the transcriptional level of CSE in VSM cells [9] . Furoxan, another NO donor, increases the level of H 2 S production induced by S-propyl-L-cysteine, an H 2 S donor, in isolated rat aortic ring [236] . NO-induced H 2 S production is mediated by cGMP as it is decreased by inhibition of sGC; thus cGMP activates H 2 S-producing enzymes [237] . In addition, CSE is the target of S-nitrosylation at its multiple reactive cysteine residues [152] . Heme-containing proteins are targets of NO, thus, the activity of CBS might be affected by NO [29] . However, another report suggests that NO could not increase the expression of H 2 S producing enzymes or levels of H 2 S in endothelial cells [238] . In addition, NO directly inhibits CSE activity in vitro with an IC 50 of about 100 nM [83] .
10.3. Interaction between NO and H 2 S on the NO/sGC/cGMP pathway H 2 S is considered to be an enhancer of NO/cGMP/sGC/PKG pathway [13] and potentiates the vasorelaxant effects of NO [181] . H 2 S increases NO-responsive form of sGC [64] and inhibits PDE 5 , which decreases cGMP degradation [13] . Reaction of H 2 S and cGMP produces 8-SH-cGMP, which is active and less sensitive to degradation by PDE 5 [13] . Inhibition of sGC and endothelial NO synthesis inhibits both H 2 Sinduced and NO-induced angiogenesis indicating the requirement of NO for angiogenesis by H 2 S [169] . In addition, NO-induced angiogenesis requires H 2 S [223], (Fig. 3) .
Effects of NO and H 2 S intermediates/metabolites on vascular tone
As shown in Fig. 4 , interaction between NO and H 2 S and their respective metabolites can produce intermediates that have distinct physiological functions as compared to both NO and H 2 S [220, [239] [240] [241] . These interactions produce different products including nitrosopersulfide (SSNO − ) [220, [242] [243] [244] [245] . S-nitrosothiols (RSNOs) are produced when NO reacts with thiol groups; and the reaction between RSNO and H 2 S produces thionitrous acid (HSNO) [241, 242, 244, 246] . HSNO could freely diffuse through the membranes, acting as an NO carrier [244, 246] . HSNO could also react with hydrogen persulfide (HSSH) to produce SSNO − , which also can act as a NO carrier, leading to relaxation of VSM cells upon NO release [220, 243, 244] . In addition, HSNO is relatively unstable and in the presence of H 2 S and HSSH can produce nitroxyl (HNO) [220, 243, 244] , which exerts vasorelaxatory effects by activation of cGMP-dependent [247] and independent [248] pathways. To sum up, interaction between NO and H 2 S is seen at the level of biosynthesis, signaling pathways, and production of some intermediates with vasoactive effects.
Role of platelets in vascular tone regulation: Effects of NO and H 2 S
The expression and function of two NOS isoforms, eNOS and iNOS, have been reported in platelets; however, their activities and regulation are controversial (reviewed in [249] ). NO produced by endothelial cells or by platelets, inhibits platelet adhesion, aggregation, recruitment, and formation of leukocyte-platelet aggregates. NO inhibits platelet activation by both cGMP-dependent and cGMP-independent pathways. In platelets, NO activates sGC and increases cGMP levels; cGMP activates PKG and inhibits almost all agonist-induced events, including increases in intracellular calcium levels [250] , integrin activation [251] , cytoskeletal reorganization, and platelet granule secretion (reviewed in [252] ). Most of the NO donors exert their inhibitory effects on platelet activation in a cGMP-independent manner [253] [254] [255] . Furthermore, activation of platelet ADP-ribosyltransferase [256] and inhibition of platelet Ca 2+ mobilization by NO in a cGMP-independent manner have also been reported [257] . Both CBS and CSE are expressed in platelets and generate detectable amounts of H 2 S [258] . Deficiency in H 2 S production stimulates platelets aggregation in a methionine-induced hyperhomocysteinemia rat model [259] . H 2 S inhibits platelet activity both in vivo and in vitro [259] [260] [261] [262] [263] [264] [265] [266] , although controversial [258] . Inhibition of platelet aggregation by H 2 S is mediated through upregulation of NOS [261, 262] , increased cAMP levels, suppression of cytosolic Ca 2+ mobilization [264] , antioxidant activity [265] , and vasodilation [266] amongst others. However, it has also been reported that H 2 S-induced inhibition of platelet aggregation is not dependent on cAMP/cGMP generation, NO production, or potassium-channels opening [260] . In contrast, a recent report showed that NaSH and Lcysteine dose-dependently enhanced platelet aggregation in hyperhomocysteinemia [258] . This discrepancy may be related to the relative doses of H 2 S employed, which has ranged from mostly high (1-10 mM) to significantly lower doses (0.1-100 μM) [258] .
NO, H 2 S and inflammation
Depending on the concentration and source of production, NO is implicated as a pro-inflammatory or an anti-inflammatory agent (reviewed in [267, 268] ). Under non-inflammatory conditions, iNOS is not expressed in endothelial cells, but in presence of pro-inflammatory stimuli, high levels of NO are produced by iNOS that contribute to inflammation [269] . The expression of iNOS in response to cytokines is also increased in VSM cells [270] , where it can prevent pathologic vasoocclusion triggered by other local mediators or increase VSM proliferation (reviewed in [271] ). On the other hand, eNOS-derived NO may serve as an anti-inflammatory agent by regulating expression of pro-inflammatory molecules such as nuclear factor kappa-light-chainenhancer of activated B cells (NF-κB) and cyclooxygenase-2 [272, 273] as well as preventing the leukocyte adhesion [274] and rolling [275] in the microvasculature. In addition, nNOS, which is predominantly expressed in the nucleus of endothelial cells, exerts an anti-inflammatory role [276] .
H 2 S has also both pro-and anti-inflammatory effects depending on its concentration as well as its rate of generation; physiological concentrations of H 2 S can exert anti-inflammatory effects, whereas higher concentrations are pro-inflammatory [277] . Thus, decreased H 2 S concentrations in the blood may contribute to vascular inflammation [278] .
Different mechanisms are involved in the anti-inflammatory effects of H 2 S, including inhibition of NF-κB and cyclooxygenase-2 [279] ; inhibition of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α [277] ; inhibition of leukocyte adherence to the vascular endothelium [280, 281] ; inhibition of iNOS expression [282] ; decreased expression of monocyte chemoattractant protein-1 (ICAM-1) [283] [284] [285] , and vascular cell adhesion molecule-1 (VCAM-1) [285] ; scavenging of ROS [286] , and upregulation of heme oxygenase-1 [285] . Inhibitory effect of H 2 S on leukocyte adhesion and infiltration is mediated through activation of K ATP [280] .
Hypertension by stimulating genes involved in the recruitment of inflammatory cells into the arterial wall exerts pro-inflammatory effects. It seems that the anti-hypertensive effects of H 2 S, at least in part, are mediated through suppression of inflammation in the endothelial.
Post-translational protein modifications by NO and H 2 S
Post-translational modifications of proteins are central molecular mechanisms that mediate signal transductions. One such modification is S-nitrosylation, which involves the addition of NO to a cysteine thiol to form an S-nitroso-protein (SNO-protein) [287] . To put this in perspective, S-nitrosylation may be comparable to that of phosphorylation and ubiquitylation, which are critical cellular regulatory mechanisms [51] . S-sulfhydration or more correctly sulfuration, is transfer of a sulfhydryl group (-SH) to a cysteine residue of a protein to form a hydropersulfide moiety (-SSH) [68, 70] or persulfide group [64] . Most of H 2 S signaling is done through protein S-sulfhydration [64] .
S-nitrosylation
Protein S-nitrosylation is a reversible modification that can activate or inhibit protein function and be beneficial or detrimental (reviewed in [288, 289] ). All mammalian cells have low levels of nitrosylated proteins, named constitutive nitrosylation [290] . S-nitrosylation is specific and only some proteins are nitrosylated despite presence of cysteine residues on almost all proteins and production of NO by most cells [291] ; it depends on the presence of metal ions (Mg 2+ or Ca 2+ ), local pH, and the acid-base motifs [228] . Peroxynitrite and NO act as specific protein posttranslational modifiers [288] . S-nitrosylation contributes to vascular tone regulation through different mechanisms including effects on cell signaling pathways and activities of PDE 5 , eNOS, and calcium channels. S-nitrosylation is involved in long-lasting inhibitory effect of NO on arterial tone; this effect is mediated by persistent increase in NO, cGMP, and S-nitrosylated cysteine residues in arteries [292] . S-nitrosylation at Cys181 of PDE 5 negatively regulates its activity and contribute to the regulation of cGMP signaling in VSM cells [293] . In addition, S-nitrosylation decreases eNOS activity by increasing its monomer formation [228] ; Snitrosylation also desensitizes sGC and decreases its response to NO in aortic smooth muscle cells [294] ; these effects can justify negative feedback on NO production.
S-nitrosylation of PKC decreases its activity and subsequently inhibits PKC-dependent contractile responses in VSM cells of mouse aorta [295] . S-nitrosoglutathione inhibits α 1 -adrenergic receptor-mediated pulmonary vasoconstriction and ligand binding likely via S-nitrosylation of its GPCR system [296] . In addition, NO donors can S-nitrosylate bradykinin receptors in aortic endothelial cells [297] and muscarinic receptors in rat atria [90] which disrupt their coupling to G proteins. In HEK-293 cells, NO by S-nitrosylation decreases binding affinity of angiotensin II type 1 receptor [298] and conductance of L-type Ca 2+ channels [299] . S-nitrosylation of connexin43 on Cys271 also regulates gap junction communication between endothelium and smooth muscle [300] .
S-sulfhydration
S-sulfhydration contributes to vascular tone regulation by affecting DNA repair, modulation of ion channels activities, and NO production. The integrity and function of endothelial cells due to DNA damage are impaired with aging and results in age-associated cardiovascular disorders [41] . In human endothelial cells, S-sulfhydration activates mitogen-activated ERK (extracellular regulated kinase) kinase (MEK1) at cysteine 341 which causes phosphorylation and translocation of extracellular regulated kinases 1 and 2 (ERK1/2) into nucleus; ERK1/2 stimulates poly(ADP-ribose)ation polymerases (PARPs) activity through direct interaction which subsequently improves DNA damage repair and cellular senescence [40] . Regulation of ion channels via S-sulfhydration has been reported in endothelial and VSM cells. For example, Ssulfhydration of K ATP channel activates it by decreasing ATP binding and increasing PIP 2 binding, which leads to hyperpolarization of VSM cells and therefore vasorelaxation; S-sulfhydration also activates IK Ca and SK Ca channels in vascular endothelial cells [83] and leads to vasorelaxation. In addition, S-sulfhydration of IP 3 R inhibits Ca 2+ release from ER and causes smooth muscle relaxation [64] . Inhibition of ROK activity by S-sulfhydration following NaSH administration has been reported in colonic smooth muscle [301] ; which can give insight into the mechanism of action of H 2 S on Rho kinase activity in VSM. H 2 S promotes PDE 5 sulfhydration, inhibits its dimerization and activity, giving rise to cGMP levels in vascular tissues [196] . Unlike S-nitrosylation which inhibits eNOS activity, S-sulfhydration of eNOS increases its activity [228] and subsequently activation of NO/sGC/PKG pathway, which causes VSM cells hyperpolarization and vasorelaxation [89] . S-sulfhydration and S-nitrosylation competitively modify the same cysteine residue of eNOS; S-sulfhydration of eNOS decreases its S-nitrosylation, while S-nitrosylation of eNOS does not affect its S-sulfhydration. Indeed, sulfhydrated cysteine is required for eNOS dimer stability [228] . H 2 S also regulates platelet activity by protein S-sulfhydration, as exposure to H 2 S increases the S-sulfhydration of platelet proteins and reduces the exocytosis of platelet granules and prolongs thrombus formation, therefore decreases expression of prothrombotic adhesion molecules on activated platelets [266] .
Conclusion and perspectives
All H 2 S-producing enzymes are found in vasculature: 3-MST has more of a contribution in endothelial cells [11] and CSE is the major enzyme in both VSM cells [9, 11] and PAT [79] . All NO-producing enzymes are also expressed in vasculature [98, 99] and eNOS [103] and nNOS [98] are the major isoforms in endothelial and VSM cells, respectively [103] . Both NO and H 2 S have roles in vascular (patho)physiology [103] and in regulating blood pressure [8] [9] [10] [11] 13] . H 2 S causes both vasorelaxation and vasoconstriction; while mechanisms underlying H 2 S-induced vasorelaxation have been identified in more details, H 2 S-induced vascular contraction needs to be more investigated as it has been suggested that H 2 S-induced vasoconstriction is physiologically more important than its relaxant activity, which needs higher concentrations [4] . Production of H 2 S and NO by blood cells may also contribute in regulation of vascular tone; this topic needs further research. Regarding effects of gasotransmitters on vascular tone, translational work in this area requires a deep understanding of the biology and pharmacology of H 2 S and NO, as well as an ability to integrate this scientific knowledge with the principles of drug development [14] . It should be noted that most data presented in these studies are from animals and in particular rodents, and although vascular regulation is generally similar in humans and rodents [83, 302] and that these data may be extrapolated to humans, we must still be cautious when doing so. In addition, it should be emphasized that while the vasorelaxatory effects of NO have been established, and has withstood the test of time, H 2 S is the youngest member of the gasotransmitter family and as such it certainly needs further work to fully elucidate its vascular and other effects.
Another area that warrants attention is the cardiovascular effect of H 2 S. This opens possibilities for a nutritionally based interventional framework. For example, it has been reported that the major beneficial effects of garlic rich diets are mediated by H 2 S production [57] . According to experimental, preclinical, and clinical studies [19, 303, 304] , elevation of H 2 S by using dietary sources or donors could be a hopeful therapeutic strategy in addressing/managing hypertension [19] . Many antihypertensive drugs exert their protective effects at least in part by increasing NO bioavailability [15] . Deficiencies in H 2 S/NO may contribute to the development of hypertension, and in this context, combination therapy may prove fruitful in managing hypertension [8, 89, 243, 305] . 
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